Camden National Bank Baxter International Inc Transaction History

Camden National Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$76.85 - $89.45 $183,902 - $214,053	-2,393 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $43,250 - $50,570	-580 Reduced 19.51%	2,393 $205,000
Q3 2021 Nov 09, 2021	SELL	$73.77 - $83.61 $1,844 - $2,090	-25 Reduced 0.83%	2,973 $239,000
Q2 2021 Aug 09, 2021	SELL	$80.5 - $88.01 $3,542 - $3,872	-44 Reduced 1.45%	2,998 $241,000
Q3 2020 Nov 05, 2020	SELL	$78.33 - $90.73 $3,916 - $4,536	-50 Reduced 1.62%	3,042 $245,000
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $15,673 - $20,432	219 Added 7.62%	3,092 $251,000
Q4 2019 Feb 11, 2020	SELL	$76.7 - $88.45 $16,797 - $19,370	-219 Reduced 7.08%	2,873 $240,000
Q3 2019 Oct 11, 2019	BUY	$81.4 - $89.78 $32,560 - $35,912	400 Added 14.86%	3,092 $270,000
Q1 2019 May 08, 2019	BUY	$64.48 - $81.31 $173,580 - $218,886	2,692 New	2,692 $219,000
Q4 2018 Feb 04, 2019	SELL	$61.45 - $77.8 $165,423 - $209,437	-2,692 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$70.71 - $77.75 $190,351 - $209,303	2,692 New	2,692 $208,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

Stay updated on Camden National Bank with notifications on news.